# Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

> **NCT07313592** · — · NOT_YET_RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DEVICE:** ChromoSeq® assay testing

## Key facts

- **NCT ID:** NCT07313592
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-31
- **Primary completion:** 2028-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313592, "Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07313592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*